Reuters logo
BRIEF-Scpharmaceuticals announces FDA acceptance of NDA for Furoscix
November 2, 2017 / 1:10 PM / 16 days ago

BRIEF-Scpharmaceuticals announces FDA acceptance of NDA for Furoscix

Nov 2 (Reuters) - Scpharmaceuticals Inc

* Scpharmaceuticals announces FDA acceptance of NDA for Furoscix (subcutaneous furosemide)

* ‍under prescription drug user fee act (PDUFA), FDA has set an action date of June 23, 2018 for Furoscix​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below